Supernatant virus release as a differentiating marker between low passage and vaccine strains of human cytomegalovirus.
- Published Article
- Publication Date
Dec 01, 1983
The ratio of CMV virus released into the supernatant per infected human fibroblast was studied for three laboratory strains and seven fresh isolates. The former all gave ratios over one whereas the latter gave ratios less than one. This phenomenon may serve as a marker of high passage attenuated virus, as about 25 passages were required in case of one strain to change this property.
Report this publication
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
This record was last updated on 07/01/2016 and may not reflect the most current and accurate biomedical/scientific data available from NLM.
The corresponding record at NLM can be accessed at https://www.ncbi.nlm.nih.gov/pubmed/6099639